Acquiring robust patent protection for chemical and pharmaceutical products and technologies, and possessing a good appreciation of any freedom-to-operate risks, is critically important to these industries.
HGF has one of the largest and most experienced teams of chemistry and pharmaceutical patent attorneys in Europe. We have over 45 patent professionals located in the UK, Germany, Austria, The Netherlands and Switzerland, and collectively we have a diverse blend of high-standard degrees and doctorates in specialist areas. Many of our attorneys also have extensive in-house experience acquired working for large multi-national companies.
We act for a global client base and cover the full spectrum of chemical technologies, including pharmaceuticals, agrochemicals, food science, cosmetics, household products, materials/metallurgy, petrochemicals, catalysis, polymer chemistry, energy, electrochemistry, printing technologies and physical chemistry.
We have established an enviable reputation in the chemistry and pharmaceutical field and continue to grow our client base, predominately by recommendation. Working closely with our clients, we devise the optimal IP strategy to achieve the best commercial outcome. We have extensive experience in the drafting, prosecution and management of world-wide patent portfolios, as well as conducting freedom-to-operate assessments, handling IP due diligence evaluations and oppositions and appeal proceedings before the European Patent Office. We also have a specialist supplementary protection certificates team for pharmaceutical and agrochemical products. In addition, our chemistry and pharmaceutical attorneys work closely with our IP lawyers in relation to life cycle agreements such as R&D collaborations, companion diagnostics, IP licensing, clinical trials through to commercial manufacturing and supply, and litigation.
Join our webinar on 1st December, where speakers from Shiga, one of the leading IP firms in Japan, will present on ‘Patent eligibility of AI-related pharmaceutical inventions and practical tips …Event details
HGF and Knobbe Martens are holding a webinar on 3rd November. Challenging granted patents: a comparison between Europe and the US In this webinar we will compare and contrast mechanisms …Event details
The IAM Patent 1000 – the world’s leading patent professionals 2021 guide has now been published. HGF has 18 European attorneys listed. IAM Patent 1000 is a unique guide that …Read article
World Intellectual Property Day is on 26th April. This year’s theme is IP & SME’s: Taking your ideas to market. World IP day 2021 shines a light on the critical role of …Event details
HGF is attending IQPC Global IP Exchange Europe 2021 virtual event being held 9 – 10 March 2021. The Global IP Exchange exclusively brings together 90 expert Chief IP Counsel, Heads and …Event details
In 2021, HGF’s IP in Healthcare Conference will be delivered virtually through a series of webinars across January, February and March. The webinars will review the latest IP and related …Event details
This week, food giant Unilever announced a €1bn annual sales target for plant-based foods within the next 5-7 years, as part of its “Future Foods” program. This ambitious target is …Read article
The prevention of cancer and development of more effective strategies to detect precursors and early-stage cancers, when treatment may be most effective, remain critical societal goals. The 2020 Bionow Oncology Conference …Event details